<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun J</submitter><funding>Chongqing Graduate Tutor Team Construction Project, Chongqing Education Commission Foundation</funding><funding>Chongqing Medical Scientific Research Project/Joint Project of Chongqing Health Commission and Science and Technology Bureau</funding><funding>National Natural Science Foundation of China</funding><funding>Nature Science Foundation of CHongqing</funding><funding>National Natural Science Foundation of China (NSFC)</funding><funding>CQMU Program for Youth Innovation in Future Medicine</funding><pagination>400-416</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11876963</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>The limited infiltration of CD8+ T cells in tumors hampers the effectiveness of T cell-based immunotherapy, yet the mechanisms that limit tumor infiltration by CD8+ T cells remain unclear. Through bulk RNA sequencing of human tumors, we identified a strong correlation between WNT7A expression and reduced CD8+ T-cell infiltration. Further investigation demonstrated that inhibiting WNT7A substantially enhanced MHC-I expression on tumor cells. Mechanistically, WNT7A inhibition inactivated the Wnt/β-catenin signaling pathway and thus resulted in reduced physical interaction between β-catenin and p65 in the cytoplasm, which increased the nuclear translocation of p65 and activated the NF-κB pathway, ultimately promoting the transcription of genes encoding MHC-I molecules. We found that our lead </pubmed_abstract><journal>Cancer immunology research</journal><pubmed_title>Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy.</pubmed_title><pmcid>PMC11876963</pmcid><funding_grant_id>W0094</funding_grant_id><funding_grant_id>cstc2021jcyj-msxmX0015 and CSTB2022NSCQ-MSX0783</funding_grant_id><funding_grant_id>NO.2021MSXM033 and 2023QNXM039</funding_grant_id><funding_grant_id>82173166</funding_grant_id><funding_grant_id>81472475 and 82273282</funding_grant_id><funding_grant_id>82372886</funding_grant_id><funding_grant_id>82103414</funding_grant_id><funding_grant_id>cqmudstd202216</funding_grant_id><pubmed_authors>Yi Z</pubmed_authors><pubmed_authors>Fang H</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Song D</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Ren G</pubmed_authors><pubmed_authors>Wang P</pubmed_authors><pubmed_authors>Du H</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy.</name><description>The limited infiltration of CD8+ T cells in tumors hampers the effectiveness of T cell-based immunotherapy, yet the mechanisms that limit tumor infiltration by CD8+ T cells remain unclear. Through bulk RNA sequencing of human tumors, we identified a strong correlation between WNT7A expression and reduced CD8+ T-cell infiltration. Further investigation demonstrated that inhibiting WNT7A substantially enhanced MHC-I expression on tumor cells. Mechanistically, WNT7A inhibition inactivated the Wnt/β-catenin signaling pathway and thus resulted in reduced physical interaction between β-catenin and p65 in the cytoplasm, which increased the nuclear translocation of p65 and activated the NF-κB pathway, ultimately promoting the transcription of genes encoding MHC-I molecules. We found that our lead </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-01T23:11:25.028Z</modification><creation>2025-04-04T02:11:07.522Z</creation></dates><accession>S-EPMC11876963</accession><cross_references><pubmed>39602462</pubmed><doi>10.1158/2326-6066.CIR-24-0484</doi></cross_references></HashMap>